Global Healthcare Clinical Trial Management System Market Overview:
Healthcare clinical trial management system is a software system which is used to manage clinical trials information in clinical research. The consistent growth of healthcare IT, high R&D expenditure by life science and clinical research companies and organizations and increasing adoption of CTMS solutions is the lucrative opportunity in the growth of the very market. Some of the key players profiled in the study are Oracle Corporation (United States), Medidata Solutions, Inc. (United States), PAREXEL International Corporation (United States), Bioclinica (United States), Bio-Optronics, Inc. (United States), IBM Corporation (United States), Bioclinica (United States), MedNet Solutions Inc. (United States), ArisGlobal LLC (United States) and DSG, Inc. (United States).
On the basis of geography, the market of Healthcare Clinical Trial Management System has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Components, the sub-segment i.e. Software will boost the Healthcare Clinical Trial Management System market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Delivery Mode, the sub-segment i.e. Cloud-based (SaaS) CTMS will boost the Healthcare Clinical Trial Management System market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Increasing Number of Partnerships between Biopharma Companies and Contract Research Organizations (CROs)
- Availability of Advanced Healthcare Clinical Trial Management System Solutions Globally
- Adoption of Platform-as-a-Service (PaaS) and Mobile Computing
- The Growth in Number of Clinical Trials by Market Players
- Budget Constraints in Various Developing Economies
- Limited Awareness among Researchers about the Advantages of Healthcare CTMS Solutions
- Surged in Number of Outsourcing of Clinical Trial Processes by Industrial Researchers to Asian Countries CROs
- Increasing Government Funding & Grants to Support Clinical Trials and Surging Customer Base for Healthcare CTMS Solutions
- Lack of Skilled Professionals in Developing Nations
In the current scenario, various market players are increasingly outsourcing their clinical trials to CROs to reduce the cost and time of the entire process, improve their global reach and extend their expertise. Thus, an increasing number in partnerships between biopharma companies and CROs are also expected to increase the adoption of these systems in the upcoming years.
Target Audience:Pharmaceutical/Biopharmaceutical Companies, Healthcare IT Service Providers, Research and Development (R&D) Companies, Clinical Research Organizations, Medical Device Manufacturing Companies, Academic Medical Centres/Universities/Hospitals and Others
Major Objectives Focused through this Study To define, describe, and forecast the Global Healthcare Clinical Trial Management System market on the basis of product [Enterprise CTMS and Site CTMS] , application [Pharmaceutical and Biopharmaceutical Companies, Contract Research Organizations (CRO), Medical Device Companies and Other], key regions and end user
To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
To provide market size for various segments of the Healthcare Clinical Trial Management System market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
To strategically profile the key players and analyzing their market shares and core competencies in the Healthcare Clinical Trial Management System industry
To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market
Available Customization: Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are .
** Confirmation on availability of data would be informed prior purchase
While framing the research framework, major and emerging players operating in the Healthcare Clinical Trial Management System market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Dow Jones (Factiva), along with primary respondents. The complete methodology includes the study of the annual and financial reports of the key market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) related to the market.